Risk factors for radiation pneumonitis following adjuvant radiotherapy for breast cancer: a retrospective cohort study - Takeaways - MDSpire

Risk factors for radiation pneumonitis following adjuvant radiotherapy for breast cancer: a retrospective cohort study

  • By

  • Chuou Yin

  • Jiang Liu

  • Juan Deng

  • Guojian Mei

  • Yingying He

  • Hui Liu

  • Hao Cheng

  • July 13, 2026

Share

  • 1

    A retrospective analysis of 811 breast cancer patients identified risk factors for radiation pneumonitis (RP) following adjuvant radiotherapy.

  • 2

    Univariate analysis revealed tumor stage, chest wall + supraclavicular + internal mammary lymph node irradiation, and mean lung dose were significantly associated with RP.

  • 3

    Multivariate analysis confirmed mean lung dose, number of chemotherapy cycles, and chest wall + supraclavicular + internal mammary lymph node irradiation as independent risk factors for RP.

  • 4

    The predictive sensitivity and specificity for RP were 0.898 and 0.965, respectively, at a mean lung dose threshold of 12.70 Gy.

  • 5

    Bootstrap internal validation confirmed the robustness of findings, emphasizing the need for stringent dosimetric constraints to minimize mean lung dose.

Original Source(s)

Related Content